000 01253 a2200385 4500
005 20250512081115.0
264 0 _c19860217
008 198602s 0 0 eng d
022 _a0033-3158
024 7 _a10.1007/BF00432517
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGlazer, W M
245 0 0 _aThe treatment of tardive dyskinesia with baclofen.
_h[electronic resource]
260 _bPsychopharmacology
_c1985
300 _a480-3 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBaclofen
_xtherapeutic use
650 0 4 _aClinical Trials as Topic
650 0 4 _aDouble-Blind Method
650 0 4 _aDyskinesia, Drug-Induced
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRandom Allocation
700 1 _aMoore, D C
700 1 _aBowers, M B
700 1 _aBunney, B S
700 1 _aRoffman, M
773 0 _tPsychopharmacology
_gvol. 87
_gno. 4
_gp. 480-3
856 4 0 _uhttps://doi.org/10.1007/BF00432517
_zAvailable from publisher's website
999 _c3941792
_d3941792